Dr. José Carlos Monteagudo Castro
Principal Investigator
Research Group on Skin Cancer
Presentation
Graduated in Medicine from the University of Valencia in 1982, Dr. Carlos Monteagudo completed his training in Anatomic Pathology (MIR) at the University Clinical Hospital of Valencia (1984-1988). He obtained a Fogarty Fellowship from the USA National Institutes of Health (NIH) for research in immunochemistry and molecular biology with Drs. Lance Liotta and Mark Sobel at the Pathology Laboratory of the National Cancer Institute (NCI), in Bethesda, Maryland (1988-1990) and a PhD degree in 1990 from the University of Valencia. He is currently Full Professor of Pathology at the University of Valencia and Chief of Dermatopathology at the University Clinical Hospital of Valencia. Member of the Editorial Committee of Scientific Reports, Revista Española de Patología, and Actas Dermosifiliográficas. He has focused during the last 30 years in two lines of research: the main one refers to the pathogenic mechanisms, diagnostic and prognostic markers of cutaneous neoplasms, with particular emphasis on melanoma. With regard to this line, he is PI of 12 research grants funded by European, national and regional public institutions. A second line, in collaboration with the University of Texas at San Antonio, TX, USA, has been dedicated to the molecular mechanisms of dissemination and virulence of systemic candidiasis. He is reviewer of research projects for the Agencia Nacional de Evaluación y Prospectiva (ANEP) and Head of the Department of Pathology of the University of Valencia since February ,2018. He is the author of 232 articles in peer reviewed journals, most of them on skin pathology which have received 5.127 citations (WoS). H-index: 33.
Publications
Acquired aggressive multisystemic disseminated lobular capillary haemangioma: a life threatening disorder. Monteagudo C, Porcar-Saura S, Navarro S, Burgues O, Gonzalez J, Ferrandez A, Forner M. Pathology. 2023 Aug;55(5):729-732. doi: 10.1016/j.pathol.2022.11.014. PMID: 36894353
Diagnostic algorithm to subclassify atypical spitzoid tumors in low and high risk according to their methylation status. González-Muñoz J, Sánchez-Sendra B, Monteagudo C. International Journal of Molecular Sciences. 2023 Dec 25;25(1):318. doi: 10.3390/ijms25010318. PMID: 38203489
Eczematous dermatitis presenting as a clear cell acanthoma-like lesion on the nipple and areola. Ballesteros Redondo M, Fernandez Domper L, Monteagudo Castro C. Actas Dermo-Sifiliograficas. 2023 Mar 23:S0001-7310(23)00220-X. doi: 10.1016/j.ad.2022.06.028. PMID: 36965773
Lymphovascular invasion and high mitotic count are associated with increased risk of recurrence in pleomorphic dermal sarcoma. Pons Benavent M, Rios-Vinuela E, Nagore E, Monteagudo C, Aguerralde M, Mata Cano D, Llombart B, Serra-Guillen C, Pinazo Canales I, Requena C, Sanmartin O. Actas Dermo-Sifiliograficas. 2023 Jul-Aug;114(7):572-579. doi: 10.1016/j.ad.2023.04.018. PMID: 37088288
Benign cephalic histiocytosis mimicking mastocytosis. Diaz E, Fernandez B, Castro C, Hernandez J. Actas Dermo-Sifiliograficas. 2022 Feb;113(2):195-198. doi: 10.1016/j.ad.2020.05.014. PMID: 35249694
Benign cephalic histiocytosis mimicking mastocytosis. Silva Diaz E, Vazquez Fernandez B, Monteagudo Castro C, Martin Hernandez J. Actas Dermo-Sifiliograficas. 2022 Feb;113(2):T195-T198. doi: 10.1016/j.ad.2022.02.001. PMID: 35244585
Clinical and pathological features of Merkel cell carcinoma: A 4-year follow-up observational retrospective study in Spain. Rios-Martin J, Rodriguez-Salas N, Vazquez-Doval F, Llombart B, Rojas-Ferrer N, Gonzalez-Vela M, Zulueta T, Monteagudo C, Aneiros-Fernandez J, Beato M, Carrillo R, Silva-Carmona M, Ayala M, Gallego E, Rodriguez-Peralto J, Fraga-Fernandez J, Fernandez-Figueras M, Barranco C, Cordoba A, Sanz-Zorrilla A, Ferrer B, Funez R, Santonja C, Saus C, Idoate M, Santos-Briz A, Onrubia J, Pinedo F, de Las Penas R. Cancer Epidemiology. 2022 Feb;76:102081. doi: 10.1016/j.canep.2021.102081. PMID: 34922051
Deep learning for skin melanocytic tumors in whole-slide images: a systematic review. Mosquera-Zamudio A, Launet L, Tabatabaei Z, Parra-Medina R, Colomer A, Moll J, Monteagudo C, Janssen E, Naranjo V. Cancers. 2022 Dec 21;15(1):42. doi: 10.3390/cancers15010042. PMID: 36612037
An attention-based weakly supervised framework for spitzoid melanocytic lesion diagnosis in whole slide images. Del Amor R, Launet L, Colomer A, Moscardo A, Mosquera-Zamudio A, Monteagudo C, Naranjo V. Artificial Intelligence in Medicine. 2021 Nov;121:102197. doi: 10.1016/j.artmed.2021.102197. PMID: 34763799
CCL27 Signaling in the Tumor Microenvironment. Martinez-Rodriguez M, Monteagudo C. Advances in Experimental Medicine and Biology. 2021;1302:113-132. doi: 10.1007/978-3-030-62658-7_9. PMID: 34286445
Cutaneous lymphadenoma is a distinct trichoblastoma-like lymphoepithelial tumor with diffuse androgen receptor immunoreactivity, notch1 ligand in reed-sternberg-like cells, and common EGFR somatic mutations. Monteagudo C, Funez R, Sanchez-Sendra B, Gonzalez-Munoz JF, Nieto G, Alfaro-Cervello C, Murgui A, Barr R. The American Journal of Surgical Pathology. 2021 Oct 1;45(10):1382-1390. doi: 10.1097/PAS.0000000000001727. PMID: 34232601
Folliculotropic mycosis fungoides with flexural eruptive cysts and comedones in a 14-year-old boy. Roca-Gines J, Alfaro-Cervello C, Sanchez-Arraez J, Torres-Navarro I, Navarro-Mira MA, Monteagudo C, Botella-Estrada R. American Journal of Dermatopathology. 2021 Sep 1;43(9):656-658. doi: 10.1097/DAD.0000000000001958. PMID: 33989213
Projects
Title: Análisis combinado por Inteligencia Artificial de marcadores epigenéticos e imágenes microscópicas digitalizadas de tumores melanocíticos ambiguos para optimizar su clasificación diagnóstica y pronóstica
Funding body: Instituto de Salud Carlos III – Cofinanciado FEDER
Principal Investigator: Carlos Monteagudo Castro
Duration: 2021 – 2023
Total budget: 220.220 €
Title: Sistema de visión artificial aumentada para la caracterización molecular y morfológica del cáncer de piel
Funding body: Agencia Valenciana de la Innovación-AVI Generalitat Valenciana
Principal Investigator: Carlos Monteagudo Castro
Duration: 2021 – 2023
Total budget: 192.869 €
Title: Cloud Artificial Intelligence for pathology-CLARIFY
Funding body: European Commission
Principal Investigator: Carlos Monteagudo Castro
Duration: 2019 – 2023
Total budget: 252000
Title: electrónicos hasta los datos MULTI-ómic
Funding body: Instituto de Salud Carlos III – Cofinanciado FEDER
Principal Investigator: Carlos Monteagudo Castro
Duration: 2018 – 2021
Total budget: 99.220 €
+ Info
Doctoral candidate: Pérez Debén, Silvia
Director(s): Domínguez Hernández, Francisco; Remohí Giménez, José
Date of the defense: 02/06/2022
University: Universitat de València